Literature DB >> 7979998

Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus.

T Tuboly1, E Nagy, J R Dennis, J B Derbyshire.   

Abstract

Seven fragments of the spike (S) gene cDNA of transmissible gastroenteritis virus (TGEV), as well as the full length cDNA, were cloned and expressed in baculovirus vectors. Piglets were immunized with cells infected with the recombinant viruses. Each of the recombinants induced TGEV-specific antibodies detected in a fixed cell enzyme immunoassay. The amino terminal half of the S protein, containing all four major antigenic sites (A, B, C and D), and encoded by a 2.2 kb fragment of the S gene, induced virus neutralizing (VN) antibody titers comparable with those induced by the complete S protein. Recombinant proteins lacking the A antigenic site, or with a deletion including the putative receptor binding sites and the D antigenic site, were not capable of inducing levels of VN antibodies similar to those induced by the whole S protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979998      PMCID: PMC7087137          DOI: 10.1007/BF01311173

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

1.  Differentiation between transmissible gastroenteritis virus and porcine respiratory coronavirus using a cDNA probe.

Authors:  R D Wesley; I V Wesley; R D Woods
Journal:  J Vet Diagn Invest       Date:  1991-01       Impact factor: 1.279

2.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.

Authors:  M Godet; D Rasschaert; H Laude
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

3.  Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein.

Authors:  B Delmas; J Gelfi; H Laude
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Comparison of intramuscular and oral modified-live virus TGE vaccines.

Authors:  E R Henning; P C Thomas
Journal:  Vet Med Small Anim Clin       Date:  1981-12

6.  Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S.

Authors:  B Delmas; D Rasschaert; M Godet; J Gelfi; H Laude
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

7.  Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus.

Authors:  I Correa; F Gebauer; M J Bullido; C Suñé; M F Baay; K A Zwaagstra; W P Posthumus; J A Lenstra; L Enjuanes
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

8.  Monoclonal antibodies to a virulent strain of transmissible gastroenteritis virus: comparison of reactivity with virulent and attenuated virus.

Authors:  S K Welch; L J Saif
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

9.  Evidence for a coiled-coil structure in the spike proteins of coronaviruses.

Authors:  R J de Groot; W Luytjes; M C Horzinek; B A van der Zeijst; W J Spaan; J A Lenstra
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

10.  Intracellular processing of the porcine coronavirus transmissible gastroenteritis virus spike protein expressed by recombinant vaccinia virus.

Authors:  D J Pulford; P Britton
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

View more
  8 in total

1.  Passive protection of piglets by recombinant baculovirus induced transmissible gastroenteritis virus specific antibodies.

Authors:  T Tuboly; E Nagy; J B Derbyshire
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

2.  The porcine microRNA transcriptome response to transmissible gastroenteritis virus infection.

Authors:  Xiao Liu; Ling Zhu; Shan Liao; Zhiwen Xu; Yuancheng Zhou
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 3.  Swinepox virus as a vaccine vector for swine pathogens.

Authors:  D N Tripathy
Journal:  Adv Vet Med       Date:  1999

4.  Assembly of pseudorabies virus genome-based transfer vehicle carrying major antigen sites of S gene of transmissible gastroenteritis virus: potential perspective for developing live vector vaccines.

Authors:  Jiechao Yin; Xiaofeng Ren; Zhijun Tian; Yijing Li
Journal:  Biologicals       Date:  2006-05-30       Impact factor: 1.856

5.  Cholesterol is important for a post-adsorption step in the entry process of transmissible gastroenteritis virus.

Authors:  Jiechao Yin; Joerg Glende; Christel Schwegmann-Wessels; Luis Enjuanes; Georg Herrler; Xiaofeng Ren
Journal:  Antiviral Res       Date:  2010-10-14       Impact factor: 5.970

6.  Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production.

Authors:  Heng Yang; Sanjie Cao; Xiaobo Huang; Jiawen Liu; Ying Tang; Xintian Wen
Journal:  Vaccine       Date:  2009-06-30       Impact factor: 3.641

7.  Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus.

Authors:  L T Jordan; J B Derbyshire
Journal:  Vet Microbiol       Date:  1995-06       Impact factor: 3.293

8.  Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

Authors:  Alexander Bukreyev; Elaine W Lamirande; Ursula J Buchholz; Leatrice N Vogel; William R Elkins; Marisa St Claire; Brian R Murphy; Kanta Subbarao; Peter L Collins
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.